QSS
HBIO icon

Quantitative Systematic Strategies’s Harvard Bioscience HBIO Stock Holding History

Quantitative Systematic Strategies’s Portfolio HBIO Stock Details HBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-1,267
Closed -$66K – 762
2018
Q3 		$66K Buy
+1,267
New +$71.1K 0.01% 590

Other funds holding HBIO

FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Quantitative Systematic Strategies's HBIO Position: Q4 2018 in Review

Quantitative Systematic Strategies sold out of Harvard Bioscience (HBIO) in Q4 2018, closing a stake of 1,267 shares — an estimated $66K sold.

Quantitative Systematic Strategies first reported a position in HBIO in Q3 2018 and held it in 1 quarter. The position peaked at $66K in Q3 2018. 80 funds tracked by Wall St. Rank hold HBIO as of Q4 2018.

  • Quantitative Systematic Strategies reported no remaining Harvard Bioscience position as of Q4 2018 after selling out during the quarter.
  • Quantitative Systematic Strategies sold 1,267 Harvard Bioscience shares in Q4 2018, an estimated $66K.
  • Quantitative Systematic Strategies first reported a position in Harvard Bioscience in Q3 2018 and held it in 1 quarter.
  • Quantitative Systematic Strategies's Harvard Bioscience position peaked at $66K in Q3 2018.
  • 80 funds tracked by Wall St. Rank held Harvard Bioscience as of Q4 2018.

Based on Quantitative Systematic Strategies's 13F filing for Q4 2018, filed 12 Feb 2019.